Form 8-K - Current report:
SEC Accession No. 0001628280-24-039948
Filing Date
2024-09-10
Accepted
2024-09-10 08:10:48
Documents
18
Period of Report
2024-09-06
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-20240906.htm   iXBRL 8-K 46997
2 EX-99.1 ex991ampclosingpr.htm EX-99.1 17937
3 EX-99.2 ex992cfoappointment.htm EX-99.2 13990
8 LOGO image_0.jpg GRAPHIC 10625
9 LOGO image_01.jpg GRAPHIC 26793
  Complete submission text file 0001628280-24-039948.txt   306661

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20240906.xsd EX-101.SCH 2258
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20240906_def.xml EX-101.DEF 15302
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20240906_lab.xml EX-101.LAB 26870
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20240906_pre.xml EX-101.PRE 16021
20 EXTRACTED XBRL INSTANCE DOCUMENT vir-20240906_htm.xml XML 3339
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 241288777
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)